Signet Healthcare Partners logo

Signet Healthcare Partners

North America, New York, United States, New York

Description

Based in New York, U.S., Signet Healthcare Partners aims to invest in commercial-stage companies in the healthcare industry.

Investor Profile

Signet Healthcare Partners has made 19 investments, with 2 in the past 12 months and 53% as lead.

Stage Focus

  • Series Unknown (32%)
  • Series B (21%)
  • Private Equity (16%)
  • Series C (16%)
  • Series D (11%)
  • Series A (5%)

Country Focus

  • United States (63%)
  • Germany (16%)
  • Norway (5%)
  • Australia (5%)
  • The Netherlands (5%)
  • Switzerland (5%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Manufacturing
  • Medical
  • Medical Device
  • Life Science
  • Genetics
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Signet Healthcare Partners frequently co-invest with?

TVM Capital
Europe, Bayern, Germany, Munich
Co-Investments: 2
AC
North America, Florida, United States, Boca Raton
Co-Investments: 1
TVM Capital Life Science
Europe, Bayern, Germany, Munich
Co-Investments: 2
TB
North America, Massachusetts, United States, Boston
Co-Investments: 1
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 2
AH
North America, Delaware, United States, Dover
Co-Investments: 1
Pharmascience
North America, Quebec, Canada, Montréal
Co-Investments: 2
Arsenal Capital Management
North America, Missouri, United States, Saint Louis
Co-Investments: 1
JW Asset Management
North America, New York, United States, New York
Co-Investments: 1
AC
Oceania, New South Wales, Australia, Sydney
Co-Investments: 2

What are some of recent deals done by Signet Healthcare Partners?

leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series DAug 6, 2024
Curida

Elverum, Hedmark, Norway

Curida is a pharmaceutical contract development and manufacturing organization (CDMO) with core competence on Blow-Fill-Seal.

BiotechnologyManufacturingPharmaceutical
Private EquityApr 15, 2024
Paragonix Technologies

Cambridge, Massachusetts, United States

Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.

BiotechnologyHealth CareMedical Device
Series BMar 7, 2023
Amount Raised: $24,000,000
Juno Pharmaceuticals

Cremorne, New South Wales, Australia

Juno Pharmaceuticals produces and distributes amoxicillin, hydrochloride syringes, hydromorphone solutions, phentermine tablets & capsules.

ManufacturingMedicalMedical DevicePharmaceuticalRetail
Private EquityFeb 24, 2022
Ascendia Pharmaceuticals

North Brunswick, New Jersey, United States

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 8, 2021
Leading Pharma

Fairfield, New Jersey, United States

A Airfield, NJ based generic pharmaceutical company .

Emergency MedicineHealth CareManufacturingPharmaceutical
Series UnknownJan 8, 2018
Amount Raised: $40,000,000
TELA Bio

Malvern, Pennsylvania, United States

TELA Bio is a life science company that specializes in soft tissue reconstruction.

BiotechnologyLife SciencePharmaceutical
Series UnknownOct 30, 2017
Amount Raised: $25,000,000
Pharmaceutics International

Hunt Valley, Maryland, United States

Pharmaceutics International operates as a science-driven contract development and manufacturing company.

Clinical TrialsHealth CareManufacturingPharmaceutical
Private EquitySep 6, 2016
Amount Raised: $93,000,000
leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series AJul 27, 2015
Amount Raised: $20,513,571
BionPharma

Princeton, New Jersey, United States

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownFeb 9, 2015
Amount Raised: $30,668,000